Enter either the number of shares you'd like to purchase OR the total investment you'd like to make.
View the INCY historical prices.
The 52 Week Low is $50.27 set on Wed, Nov 1, 2023.
The 52 Week High is $75.74 set on Mon, Mar 6, 2023. The current price, $51.68, is 0% below the 52 Week High.
The All-Time High is $25.19 set on Wed, Feb 4, 1998. The current price, $51.68, is 0% below the All Time High.
Below is the most recent stock split information. View INCY stock split history.
Stock Split Ex Date
Adjustment Factor
INCY has no dividend history.
Annual Dividend Yield
Quarterly Dividend Rate
Declaration Date
Ex-Dividend Date
Record Date
Payment Date
Dividend Frequency
Dividend History
Incyte focuses on the discovery and development of small-molecule drugs. The firm's lead drug, Jakafi, treats two types of rare blood cancer and graft versus host disease and is partnered with Novartis. Incyte's other marketed drugs include rheumatoid arthritis treatment Olumiant (licensed to Lilly), and oncology drugs Iclusig (chronic myeloid leukemia), Pemazyre (cholangiocarcinoma), Tabrecta (lung cancer), and Monjuvi (diffuse large B-cell lymphoma). The firm's first dermatology product, Opzelura, was approved in 2021 for atopic dermatitis and 2022 for vitiligo. Incyte's pipeline includes a broad array of oncology and dermatology programs.
Did you know you can earn $30 back on your first $30 of qualifying purchases with Rakuten?
Join now and start saving on every purchase from top retailers like Target, eBay, Zappos, Walmart, Kohl's & CVS. Whether you're shopping for fashion, electronics, home essentials, or health products, Rakuten makes it rewarding.
Sign up through this link and explore the endless possibilities to save and earn cash back!
Check out the Symbol Surfing blog to learn about investing.